BioAge Labs BIOA
NASDAQ BIOA
$5.87 +0.09 (+1.56%)
At close: Nov 11, 2026 · 4:00 PM EST

BioAge Labs (BIOA) Construction in Progress (2024 - 2026)

Updated

Analysis

BioAge Labs (BIOA) Construction in Progress (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 BioAge Labs 265.60 Mn -1.75 Bn -21.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 149.00
Dec 31, 2025 22.00
Dec 31, 2024 176.00
API Access

BioAge Labs Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BIOA&period=max&api_key=YOUR_API_KEY